Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Response to letter to the editor: let’s be attentive to the CD83 antigen expression in dendritic cell!

Borges MN, Nazário AC.

Sao Paulo Med J. 2013;131(2):138. No abstract available.

2.

CD83 antigen expression and its role in the progression of systemic malignancies.

Kapoor S.

Sao Paulo Med J. 2013;131(2):137. No abstract available.

PMID:
23798069
3.

Analysis of CD83 antigen expression in human breast fibroadenoma and adjacent tissue.

Borges MN, Facina G, Silva ID, Waitzberg AF, Nazario AC.

Sao Paulo Med J. 2011 Dec;129(6):402-9.

4.
5.
6.

Hodgkin's cells express CD83, a dendritic cell lineage associated antigen.

Sorg UR, Morse TM, Patton WN, Hock BD, Angus HB, Robinson BA, Colls BM, Hart DN.

Pathology. 1997 Aug;29(3):294-9.

PMID:
9271021
7.

Prognostic significance of CD83 positive tumor-infiltrating dendritic cells and expression of TGF-beta 1 in human gastric cancer.

Ananiev J, Gulubova MV, Manolova IM.

Hepatogastroenterology. 2011 Sep-Oct;58(110-111):1834-40. doi: 10.5754/hge10320.

PMID:
22086706
8.

In vitro generation of CD83+ human blood dendritic cells for active tumor immunotherapy.

Thurnher M, Papesh C, Ramoner R, Gastl G, Böck G, Radmayr C, Klocker H, Bartsch G.

Exp Hematol. 1997 Mar;25(3):232-7.

PMID:
9091299
9.

Efficient presentation of tumor idiotype to autologous T cells by CD83(+) dendritic cells derived from highly purified circulating CD14(+) monocytes in multiple myeloma patients.

Ratta M, Curti A, Fogli M, Pantucci M, Viscomi G, Tazzari P, Fagnoni F, Vescovini R, Sansoni P, Tura S, Lemoli RM.

Exp Hematol. 2000 Aug;28(8):931-40.

PMID:
10989194
10.

Expression of antigen tf and galectin-3 in fibroadenoma.

Gallegos IB, Pérez-Campos E, Martinez M, Mayoral MÁ, Pérez L, Aguilar S, Zenteno E, Pina Mdel S, Hernández P.

BMC Res Notes. 2012 Dec 24;5:694. doi: 10.1186/1756-0500-5-694.

11.

The soluble form of CD83 is present at elevated levels in a number of hematological malignancies.

Hock BD, Haring LF, Steinkasserer A, Taylor KG, Patton WN, McKenzie JL.

Leuk Res. 2004 Mar;28(3):237-41.

PMID:
14687618
12.

In situ localization of CD83-positive dendritic cells in psoriatic lesions.

Koga T, Duan H, Urabe K, Furue M.

Dermatology. 2002;204(2):100-3.

PMID:
11937733
13.

Immunological and radioimmunological studies of membrane antigen(s) from human breast carcinomas and non-tumoral breast tissues. I.

Bartorelli A, Accinni R.

Experientia. 1977 Jan 15;33(1):85-7. No abstract available.

PMID:
836430
14.

Prognostic significance of CD83 positive, mature dendritic cells in the gallbladder carcinoma.

Furihata M, Ono Y, Ichikawa K, Tomita S, Fujimori T, Kubota K.

Oncol Rep. 2005 Aug;14(2):353-6.

PMID:
16012714
15.

In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas.

Bell D, Chomarat P, Broyles D, Netto G, Harb GM, Lebecque S, Valladeau J, Davoust J, Palucka KA, Banchereau J.

J Exp Med. 1999 Nov 15;190(10):1417-26.

16.

[Expression of the adhesion molecule CD44v6 in infiltrating ductal carcinomas of the breast is associated with hormone dependence. Our experience with 168 cases].

Ruibal A, Schneider J, del Río MC, Arias J, Núñez MI, Tejerina A.

Rev Esp Med Nucl. 2000 Sep;19(5):350-5. Spanish.

18.

Up-regulation of the dendritic cell marker CD83 on polymorphonuclear neutrophils (PMN): divergent expression in acute bacterial infections and chronic inflammatory disease.

Iking-Konert C, Wagner C, Denefleh B, Hug F, Schneider M, Andrassy K, Hansch GM.

Clin Exp Immunol. 2002 Dec;130(3):501-8.

19.
20.

Distribution and density of CD1a+ and CD83+ dendritic cells in HPV-associated laryngeal papillomas.

Kovalenko S, Lukashenko P, Romanovskaya A, Soldatski IL, Bakanov SI, Pfister H, Gerein V.

Int J Pediatr Otorhinolaryngol. 2009 Feb;73(2):249-56. doi: 10.1016/j.ijporl.2008.10.016. Epub 2008 Dec 4.

PMID:
19062106
Items per page

Supplemental Content

Write to the Help Desk